Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer

D. M. Janzen; E. Tiourin; J. A. Salehi; D. Y. Paik; J. Lu; M. Pellegrini; S. Memarzadeh

doi:10.1038/s41467-020-15721-y

Nature Communications (Apr 2020)

Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer

D. M. Janzen,
E. Tiourin,
J. A. Salehi,
D. Y. Paik,
J. Lu,
M. Pellegrini,
S. Memarzadeh

Affiliations

D. M. Janzen: Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles
E. Tiourin: Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles
J. A. Salehi: Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles
D. Y. Paik: Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles
J. Lu: Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles
M. Pellegrini: Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles
S. Memarzadeh: Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles

DOI: https://doi.org/10.1038/s41467-020-15721-y
Journal volume & issue: Vol. 11, no. 1
pp. 1 – 1

Abstract

Read online

This Article has been retracted; see accompanying Retraction Note. A previous correction is no longer appended to the PDF version of this paper but can be accessed here: https://doi.org/10.1038/ncomms10703 .

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal